Citizens JMP lowered the firm’s price target on Bowhead Specialty (BOW) to $40 from $43 and keeps an Outperform rating on the shares. The firm expects Q3 results for the insurance sector to be highlighted by lighter-than-typical catastrophe losses, modest mark to market book value tailwinds, and potential for continued issues around casualty loss reserves, but thinks focus will be zeroed in on the pricing environment, the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BOW:
- Bowhead Specialty price target lowered to $33 from $39 at JPMorgan
- Bowhead Specialty price target lowered to $31 from $34 at Morgan Stanley
- Bowhead Specialty price target lowered to $38 from $42 at Keefe Bruyette
- Bowhead Specialty Expands Board with New Director
- Bowhead Specialty price target lowered to $33 from $38 at Piper Sandler